EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer

Elitsa Boneva, Velizar Shivarov, Milena Ivanova

Immuno · 02.03.2025 · 5 (1) · 9

DOI: 10.3390/immuno5010009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immuno, online erschienen am 02.03.2025. Verfasst von Elitsa Boneva und 2 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund grant (Bulgaria).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune system’s ability to detect and eliminate transformed cells is a critical factor in suppressing cancer development. However, immune surveillance in tumors is often disrupted by various immune escape mechanisms, many of which remain poorly understood. The Natural Killer Group 2D (NKG2D) receptor is an activating receptor expressed on natural killer (NK) cells and cytotoxic T lymphocytes. It can recognize and bind with varying affinities to a wide range of structurally diverse ligands, including MHC class I chain-related proteins A and B (MICA and MICB) and members of the ULBP family (ULBP1-6). The expression of these ligands plays a crucial role in immune antitumor responses and cancer immunoevasion mechanisms. Some evidence suggests that functional polymorphisms in the NKG2D receptor and the genes encoding its ligands significantly influence HLA-independent cancer immunosurveillance. Consequently, the NKG2D-NKG2D ligands (NKG2DLs) axis represents a promising target for developing novel therapeutic strategies. This review aims to provide a general overview of the role of NKG2D and its ligands in various malignancies and explore their potential in advancing personalized cancer treatment protocols.

Förderung

  • National Science Fund grant (Bulgaria)

Zitieren

APA

Boneva, E., Shivarov, V., & Ivanova, M. (2025). A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer. Immuno, 5(1), 9. https://doi.org/10.3390/immuno5010009

Vancouver

Boneva E, Shivarov V, Ivanova M. A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer. Immuno. 2025;5(1):9. doi:10.3390/immuno5010009

BibTeX
@article{Boneva2025,
  author = {Boneva, Elitsa and Shivarov, Velizar and Ivanova, Milena},
  title = {A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer},
  journal = {Immuno},
  year = {2025},
  volume = {5},
  number = {1},
  pages = {9},
  doi = {10.3390/immuno5010009}
}
Kostenlos starten →